Full Press Release Details
Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team.
RARE
Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
Key Takeaway: Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia